- BSX Stock Page
Boston Scientific Corp. (NYSE:BSX)
Last Update: 5 hours ago
| Change: | 0.34 (2.72%) |
| Last Trade: | 12.84 |
| Prev Close: | 12.50 |
| Share Volume: | 7,443,556 |
| Market Cap: | 18.71B |
| EPS (Earnings per share): | -0.21 |
| P/E (Price/earning ratio): | N/A |
| P/B (Price/book ratio): | 1.23 |
| Stock Price History | |
|---|---|
| Beta: | 0.81 |
| 52 week change: | -1.70% |
| 52 week high: | 15.31 |
| 52 week low: | 10.76 |
| 50 day moving avarage: | 12.72 |
| 200 day moving avarage: | 12.90 |
| Dividends | |
| Ex dividend date: | N/A |
| Dividend yield: | N/A |
| Dividend rate: | N/A |
| Share Statistics | |
| Avarage 10 day volume: | 8,881,444 |
| Shares outstanding: | 1,500,640,038 |
| Short interest date: | Jul 28, 2008 |
| Short shares: | 24,883,306 |
| Short ratio: | 1.50 |
| Short % of float: | 1.70% |
Thu, 28 Aug 2008 6:15 PM
After-Hours:
12.70
-0.14 (-1.09%)
| Today | 5d | 1m | 3m | 6m | 1y | 5y |
Latest Headlines for BSX
Company Profile
Sector: Healthcare
Industry: Health Services
Dev/mfr/mkt medical devices
A developer, manufacturer and marketer of medical devices that are used in carrdiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology and neuromodulation.
BSX Headlines
-
Aug 26 at 5:01 ET
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 -
Jul 21 at 5:01 ET
Boston Scientific Announces Results for Second Quarter Ended June 30, 2008 -
Jul 21 at 10:59 ET
Seven Summits Research Releases Comments on WB, MOT, WFMI, MAR, and BSX -
Jul 02 at 5:23 ET
Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System -
Jun 30 at 6:24 ET
UPDATE: Iraq Sues Oilmen, Cos Over Oil-For-Food Corruption -
Jun 30 at 5:11 ET
Iraq Sues Oilmen, Cos Over Alleged Oil-For-Food Corruption -
Jun 30 at 5:11 ET
Iraq Sues Oilmen, Cos Over Alleged Oil-For-Food Corruption -
Jun 26 at 2:35 ET
Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results -
Jun 24 at 4:15 ET
Coated Stents Show Benefit Without Heightened Risk -Study -
Jun 23 at 8:30 ET
Boston Scientific Welcomes Progress on Pain Care Legislation
Top members owning BSX
-
Top 5%
-1.03%3m:
11.60%YTD:
-
Top 32%
0.02%3m:
8.66%YTD:
-
Top 87%
-15.37%3m:
-4.47%YTD: